HOXA9 and neoplasm: Studies of mouse xenograft models revealed that expression of HOXA9 in EOC cells promotes growth of solid peritoneal implants by inducing normal peritoneal fibroblasts and mesenchymal stem cells to acquire features of cancer-associated fibroblasts that in turn supported tumor growth and angiogenesis[10].